MDXG Relative Valuation
MDXG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MDXG is overvalued; if below, it's undervalued.
Historical Valuation
MiMedx Group Inc (MDXG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 7.02. The fair price of MiMedx Group Inc (MDXG) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 6.90 USD , MiMedx Group Inc is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：6.90
Fair
Undervalued
21.90
PE
1Y
3Y
5Y
Trailing
Forward
9.65
EV/EBITDA
MiMedx Group Inc. (MDXG) has a current EV/EBITDA of 9.65. The 5-year average EV/EBITDA is 9.76. The thresholds are as follows: Strongly Undervalued below -62.67, Undervalued between -62.67 and -26.46, Fairly Valued between 45.97 and -26.46, Overvalued between 45.97 and 82.18, and Strongly Overvalued above 82.18. The current Forward EV/EBITDA of 9.65 falls within the Historic Trend Line -Fairly Valued range.
14.63
EV/EBIT
MiMedx Group Inc. (MDXG) has a current EV/EBIT of 14.63. The 5-year average EV/EBIT is -8.72. The thresholds are as follows: Strongly Undervalued below -84.43, Undervalued between -84.43 and -46.57, Fairly Valued between 29.14 and -46.57, Overvalued between 29.14 and 66.99, and Strongly Overvalued above 66.99. The current Forward EV/EBIT of 14.63 falls within the Historic Trend Line -Fairly Valued range.
2.47
PS
MiMedx Group Inc. (MDXG) has a current PS of 2.47. The 5-year average PS is 2.72. The thresholds are as follows: Strongly Undervalued below 0.58, Undervalued between 0.58 and 1.65, Fairly Valued between 3.79 and 1.65, Overvalued between 3.79 and 4.86, and Strongly Overvalued above 4.86. The current Forward PS of 2.47 falls within the Historic Trend Line -Fairly Valued range.
11.00
P/OCF
MiMedx Group Inc. (MDXG) has a current P/OCF of 11.00. The 5-year average P/OCF is 8.34. The thresholds are as follows: Strongly Undervalued below -7.90, Undervalued between -7.90 and 0.22, Fairly Valued between 16.45 and 0.22, Overvalued between 16.45 and 24.57, and Strongly Overvalued above 24.57. The current Forward P/OCF of 11.00 falls within the Historic Trend Line -Fairly Valued range.
11.06
P/FCF
MiMedx Group Inc. (MDXG) has a current P/FCF of 11.06. The 5-year average P/FCF is 9.77. The thresholds are as follows: Strongly Undervalued below -6.52, Undervalued between -6.52 and 1.62, Fairly Valued between 17.92 and 1.62, Overvalued between 17.92 and 26.06, and Strongly Overvalued above 26.06. The current Forward P/FCF of 11.06 falls within the Historic Trend Line -Fairly Valued range.
MiMedx Group Inc (MDXG) has a current Price-to-Book (P/B) ratio of 4.31. Compared to its 3-year average P/B ratio of 47.32 , the current P/B ratio is approximately -90.88% higher. Relative to its 5-year average P/B ratio of -10.55, the current P/B ratio is about -140.89% higher. MiMedx Group Inc (MDXG) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.41%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 0.40% , the current FCF yield is about -100.00% lower.
4.25
P/B
Median3y
47.32
Median5y
-10.55
6.48
FCF Yield
Median3y
2.41
Median5y
0.40
Competitors Valuation Multiple
The average P/S ratio for MDXG's competitors is 5.44, providing a benchmark for relative valuation. MiMedx Group Inc Corp (MDXG) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 35.30%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MDXG decreased by 28.69% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 9.37 to 14.73.
The secondary factor is the Revenue Growth, contributed 35.30%to the performance.
Overall, the performance of MDXG in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is MiMedx Group Inc (MDXG) currently overvalued or undervalued?
What is MiMedx Group Inc (MDXG) fair value?
How does MDXG's valuation metrics compare to the industry average?
What is the current P/B ratio for MiMedx Group Inc (MDXG) as of Dec 05 2025?
What is the current FCF Yield for MiMedx Group Inc (MDXG) as of Dec 05 2025?
What is the current Forward P/E ratio for MiMedx Group Inc (MDXG) as of Dec 05 2025?